← back to search

Xiao‐Jing Yu

Novartis (Switzerland) · CH
Area of research
Cardiology and Cardiovascular Medicine · Surgery
Research interest
Research interests include Renin-Angiotensin System Studies, Cardiovascular, Neuropeptides, and Oxidative Stress Research, Stress Responses and Cortisol, and Regulation of Appetite and Obesity.
h-index
36
citations
4,637
works
153
NIH funding
primary concept
email

Recent publications

Blockade of Microglial Activation in Hypothalamic Paraventricular Nucleus Improves High Salt-Induced Hypertension
American Journal of Hypertension 2022cited by 27position: firstdoi
Beneficial effects of metformin supplementation in hypothalamic paraventricular nucleus and arcuate nucleus of type 2 diabetic rats
Toxicology and Applied Pharmacology 2022cited by 8position: firstdoi
Paraventricular Nucleus Infusion of Oligomeric Proantho Cyanidins Improves Renovascular Hypertension
Frontiers in Neuroscience 2021cited by 22position: firstdoi
Chronic Infusion of Astaxanthin Into Hypothalamic Paraventricular Nucleus Modulates Cytokines and Attenuates the Renin–Angiotensin System in Spontaneously Hypertensive Rats
Journal of Cardiovascular Pharmacology 2021cited by 16position: middledoi
Antihypertensive effects of exercise involve reshaping of gut microbiota and improvement of gut-brain axis in spontaneously hypertensive rat
Gut Microbes 2020cited by 148position: middledoi
Irisin lowers blood pressure by activating the Nrf2 signaling pathway in the hypothalamic paraventricular nucleus of spontaneously hypertensive rats
Toxicology and Applied Pharmacology 2020cited by 53position: middledoi
Central Blockade of E-Prostanoid 3 Receptor Ameliorated Hypertension Partially by Attenuating Oxidative Stress and Inflammation in the Hypothalamic Paraventricular Nucleus of Spontaneously Hypertensive Rats
Cardiovascular Toxicology 2020cited by 16position: middledoi
Exercise Training Attenuates Hypertension Through TLR4/MyD88/NF-κB Signaling in the Hypothalamic Paraventricular Nucleus
Frontiers in Neuroscience 2019cited by 42position: middledoi
Carbon Monoxide Attenuates High Salt-Induced Hypertension While Reducing Pro-inflammatory Cytokines and Oxidative Stress in the Paraventricular Nucleus
Cardiovascular Toxicology 2019cited by 23position: middledoi
Chronic Intracerebroventricular Infusion of Metformin Inhibits Salt-Sensitive Hypertension via Attenuation of Oxidative Stress and Neurohormonal Excitation in Rat Paraventricular Nucleus
Neuroscience Bulletin 2018cited by 18position: firstdoi
Angiotensin-(1-7) attenuates hypertension and cardiac hypertrophy <i>via</i> modulation of nitric oxide and neurotransmitter levels in the paraventricular nucleus in salt-sensitive hypertensive rats
RSC Advances 2018cited by 8position: middledoi
Exercise Training Attenuates Hypertension and Cardiac Hypertrophy by Modulating Neurotransmitters and Cytokines in Hypothalamic Paraventricular Nucleus
PLoS ONE 2014cited by 56position: middledoi
Chronic infusion of enalaprilat into hypothalamic paraventricular nucleus attenuates angiotensin II-induced hypertension and cardiac hypertrophy by restoring neurotransmitters and cytokines
Toxicology and Applied Pharmacology 2013cited by 46position: middledoi
Renin–Angiotensin System Modulates Neurotransmitters in the Paraventricular Nucleus and Contributes to Angiotensin II-Induced Hypertensive Response
Cardiovascular Toxicology 2012cited by 59position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yu‐Ming Kang · Ministry of Education of the People's Republic of China14 papers (2012–2022)Kai‐Li Liu · Harbin Medical University9 papers (2018–2022)Ying Li · Jinan University8 papers (2018–2021)Jie Qi · Guizhou Water Conservancy and Hydropower Survey and Design Institute7 papers (2012–2022)Liyan Fu · Tianjin University of Traditional Chinese Medicine7 papers (2019–2022)Guo‐Qing Zhu · Shandong University6 papers (2013–2021)Kai B. Kang · University of Illinois Chicago6 papers (2019–2021)Hong‐Bao Li · University of Florida6 papers (2014–2020)Xiao‐Lian Shi · Ministry of Education of the People's Republic of China6 papers (2019–2022)Qing Su · Guangzhou University of Chinese Medicine6 papers (2013–2020)Hong‐Li Gao · Xi'an Jiaotong University5 papers (2018–2022)Jinjun Liu · The University of Texas Medical Branch at Galveston3 papers (2020–2021)Jie Qi · Xi'an Jiaotong University3 papers (2019–2021)Qiu-Yue Yi · Nanjing Tech University3 papers (2020–2021)Yuping Suo · Shanxi Medical University3 papers (2012–2014)Zhiming Zhu · Allen Institute for Brain Science2 papers (2012–2014)Dongmei Zhang · Heilongjiang Academy of Sciences2 papers (2012–2013)Yanmei Chen · Kunming University of Science and Technology2 papers (2019–2022)Yaojun Sun · Shanxi Medical University2 papers (2020–2021)Yanan Zhao · Hebei Medical University2 papers (2018–2018)